Navigation Links
Access MediQuip Announces Release of the Country's First Centralized Recall Management Service(SM) for Implantable Devices
Date:3/17/2010

LAKE MARY, Fla., March 17 /PRNewswire/ -- Access MediQuip, LLC, the nation's first and largest provider of outsourced implantable medical device management solutions to the healthcare industry, announced today it has enhanced its proprietary Recall Management Service, "RMS," for its customers nationwide. The new release is designed to protect patients, inform and empower surgeons and facilities, and help payers improve quality while managing cost.

"Access MediQuip has a long history of offering a wide array of solutions to those in the implantable medical device field," said Access MediQuip Chief Executive Officer Tim Hargarten. "With the release of RMS we are now able to provide benefits that extend beyond traditional cost management into the realms of quality and patient safety."

RMS leverages its expansive database of facility, device, and case related information to identify potentially affected patients through a series of reactive and proactive processes. This capability allows RMS to recognize patients who have already received a defective device, as well as those currently scheduled to receive one. These safeguards help payers realize substantial savings by avoiding unnecessary procedural costs and enabling providers to deliver higher quality patient care.

"One of the greatest challenges we face during a medical device recall event is the lack of readily available information," said Dr. Fabian D'Souza, founding President of Boston Strategic Partners Inc. "The process of pulling procedural records and correlating them to specific implanted devices, with various serial and lot numbers, is both costly and highly inefficient. RMS has streamlined this process by providing notifications of which patients were potentially affected and their corresponding case information."

About Access MediQuip

Access MediQuip was founded in 1997 and is the nation's first and largest provider of outsourced implantable medical device management solutions. The company works with thousands of payers, manufacturers and providers to manage the acquisition, financing, delivery and reimbursement of implantable medical devices such as orthopedic and spinal implants. The company is headquartered in Lake Mary, Florida. For more information, please visit www.accessmediquip.com.

SOURCE Access MediQuip, LLC

Back to top

RELATED LINKS
http://www.accessmediquip.com

'/>"/>

SOURCE Access MediQuip, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Japan , Dec. 9, 2016 Mitsubishi ... ; President & Representative Director, CEO: Dr. Masayuki ... amyotrophic lateral sclerosis (ALS) given edaravone intravenously in 10-14 ... loss as measured by the ALS Functional Rating Scale-Revised ... International Symposium on ALS/MND in Dublin, ...
(Date:12/9/2016)... DUBLIN , Dec 9, 2016 Research ... Vaccines Market 2016-2020" report to their offering. ... The global travel vaccines market ... The report covers the present scenario and the growth ... the market size, the report considers the revenue generated from the ...
(Date:12/9/2016)... Dec. 9, 2016  Forge Therapeutics, Inc. today ... Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) to advance ... the treatment of bacterial infections including those caused ... as an attractive antibacterial target for more than ... suitable chemical starting points has hampered its progress. ...
Breaking Medicine Technology:
(Date:12/9/2016)... Northern Kentucky - Cincinnati, Ohio (PRWEB) , ... ... ... leader in the production of miniature, folded, pharmaceutical inserts and outserts. As ... & Serialization Device. This addition will enable Flottman to individually code professional ...
(Date:12/9/2016)... , ... December 09, 2016 , ... The Justin ... Dependence, Inc. (NCADD) is recommending the film Whispering Spirits and its ... District of Columbia as an education tool in the war against teen drug abuse. ...
(Date:12/9/2016)... ... ... An inventor from Cana, Va., wanted to fulfill the need for a ... , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates discrimination. It is ... in a matter of minutes, or even seconds. The SAFETY STRAP FOR AMPUTEES is ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy ... in New York, NY, on December 3rd, to benefit Holy Name Medical Center's ... annual event, which raised over $1 million - the largest event in the ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... "I had ... an inventor from Winchester, Va. "I thought that if the nebulizer had a more ... rather than fearing them." , He developed the patent-pending NEBY to avoid the need ...
Breaking Medicine News(10 mins):